Screener
Abbott ABT Medical Devices — Operating Earnings
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Abbott in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The source filing: Abbott’s 10-Q, filed July 28, 2026.
- Filed
- Jul 28, 2026, 4:02 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-050134
| (in millions) | Net Sales to External Customers / Three Months Ended June 30, 2026 | Net Sales to External Customers / Three Months Ended June 30, 2025 | Cost of Products Sold / Three Months Ended June 30, 2026 | Cost of Products Sold / Three Months Ended June 30, 2025 | Research and Development / Three Months Ended June 30, 2026 | Research and Development / Three Months Ended June 30, 2025 | Selling, General, and Administrative / Three Months Ended June 30, 2026 | Selling, General, and Administrative / Three Months Ended June 30, 2025 | Operating Earnings / Three Months Ended June 30, 2026 | Operating Earnings / Three Months Ended June 30, 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Established Pharmaceuticals | $1,499 | $1,383 | $(650) | $(631) | $(48) | $(43) | $(419) | $(363) | $382 | $346 |
| Nutritional Products | 2,144 | 2,212 | (1,148) | (1,155) | (54) | (54) | (574) | (585) | 368 | 418 |
| Diagnostic Products | 3,092 | 2,173 | (1,532) | (1,224) | (268) | (154) | (793) | (423) | 499 | 372 |
| Medical Devices | 5,853 | 5,369 | (1,925) | (1,758) | (470) | (430) | (1,489) | (1,385) | 1,969 | 1,796 |
| Total | $12,588 | $11,137 | $(5,255) | $(4,768) | $(840) | $(681) | $(3,275) | $(2,756) | $3,218 | $2,932 |
| Other | 5 | 5 | ||||||||
| Net sales | $12,593 | $11,142 | ||||||||
| Corporate functions and plan benefit costs | (45) | (65) |
Item 1. Financial Statements and Supplementary Data
FAQ
- What is Abbott's medical devices — operating earnings?
- Abbott (ABT) reported medical devices — operating earnings of $1.97B in Q2 2026.
- How has Abbott's medical devices — operating earnings changed year-over-year?
- Abbott's medical devices — operating earnings increased by 9.6% year-over-year, from $1.8B to $1.97B.
- What is the long-term trend for Abbott's medical devices — operating earnings?
- Over 4 years (2021 to 2025), Abbott's medical devices — operating earnings has grown at a 12.4% compound annual growth rate (CAGR), from $4.51B to $7.21B.
- What does medical devices — operating earnings mean?
- Represents the profit generated by the medical devices segment after deducting operating expenses from net sales. It serves as the primary measure of the segment's core operational profitability and performance. This metric excludes interest, taxes, and corporate-level allocations.
Ask your AI about Abbott's medical devices — operating earnings.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude